Syros Pharmaceuticals' Series B Round

Syros Pharmaceuticals raised a round of funding on October 27, 2014.

Syros Pharmaceuticals is a therapeutics company harnessing breakthroughs in gene control to revolutionize the treatment of cancer and other diseases. Syros' platform identifies the master switches for…

Articles about Syros Pharmaceuticals' Series B Round: